Journal article · 2026 · Open access
Long-Term Survival After Initial Invasive or Conservative Management of Stable Coronary Disease in ISCHEMIA-EXTEND
JAMA · Published 7 November 2026 · DOI 10.1001/jama.2026.20375
In brief
“Long-Term Survival After Initial Invasive or Conservative Management of Stable Coronary Disease in ISCHEMIA-EXTEND” is a 2026 journal article by Judith S. Hochman and 207 co-authors, published in JAMA. OpenAlex counts 1 citations as of 17 November 2026. It is open access: the full text is free to read at PubMed Central.
- Citations
- 1
- Most cited in
- 2026 (1)
- Field-weighted impact
- 3.04
- References
- 25
- Authors
- 208
Abstract
Importance: It is unknown whether routine invasive management of chronic coronary disease improves long-term survival when added to guideline-directed medical therapy. Objective: To compare the effects of initial invasive and conservative strategies on long-term mortality in patients with chronic coronary disease. Design, Setting, and Participants: In this long-term follow-up study of the International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA), an international trial of patients with chronic coronary disease, moderate or severe ischemia, left ventricular ejection fraction of 35% or more, and no left main coronary artery disease, unacceptable angina, or recent acute coronary syndrome, participants were randomized at 320 sites in 37 countries beginning August 2012 and followed up through December 2025. Data were analyzed using the intention-to-treat principle. Intervention: ISCHEMIA randomized patients to an initial invasive strategy of guideline-directed medical therapy plus coronary angiography and revascularization (when feasible) or an initial conservative strategy with guideline-directed medical therapy alone, with invasive management for failure of medical therapy. Main Outcomes and Measures: All-cause, cardiovascular, and noncardiovascular mortality were analyzed using cumulative incidence estimates, Cox and Fine-Gray models, bayesian analysis, and restricted mean survival time. Results: Among 5179 participants, median age was 64 (IQR, 58-70) years; 23% were female, 42% had diabetes, and median ejection fraction was 60% (IQR, 55%-65%). During 9-year median follow-up (range, 1 day to 13.4 years), 1071 deaths occurred (782 during extended follow-up): 672 cardiovascular, 359 noncardiovascular, and 40 unclassified. All-cause 11-year mortality was not significantly different between groups (25.8% invasive vs 26.9% conservative; estimated difference, -1.0 percentage point [95% CI, -4.2 to 2.1 percentage points]; adjusted hazard ratio [AHR], 0.97 [95% CI, 0.86-1.09]). By bayesian analysis, the posterior probability of more than 1 percentage-point survival benefit to invasive vs conservative was low (18%). Cardiovascular mortality at 11 years was 15.8% in the invasive group vs 17.1% in the conservative group (estimated difference, -1.4 percentage points [95% CI, -4.0 to 1.3 percentage points]; AHR, 0.88 [95% CI, 0.75-1.02]). Noncardiovascular mortality at 11 years was 9.1% in the invasive group vs 8.1% in the conservative group (estimated difference, 1.0 percentage point [95% CI, -0.9 to 2.9 percentage points]; AHR, 1.18 [95% CI, 0.96-1.45]). Eleven-year restricted mean survival was not significantly different (estimated difference, 14 days [95% CI, -41 to 70 days]). Conclusions and Relevance: In this study, long-term all-cause mortality in patients with high-risk chronic coronary disease was not significantly different after routine invasive vs initial conservative management. Trial Registration: ClinicalTrials.gov Identifier: NCT04894877.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Hochman, J. S., Anthopolos, R., Reynolds, H. R., Bangalore, S., Xu, Y., O’Brien, S. M., Boumakis, S., Chang, M., Rosenberg, Y., Senior, R., Banfield, A., Goodman, S. G., Lopes, R. D., Pracoń, R., Lopez-Sendon, J. L., Steg, P. G., Maggioni, A. P., Newman, J. D., Berger, J. S., . . . John, M. G. B. (2026). Long-Term Survival After Initial Invasive or Conservative Management of Stable Coronary Disease in ISCHEMIA-EXTEND. JAMA. https://doi.org/10.1001/jama.2026.20375
MLA 9
Hochman, Judith S., et al. “Long-Term Survival After Initial Invasive or Conservative Management of Stable Coronary Disease in ISCHEMIA-EXTEND.” JAMA, 2026. https://doi.org/10.1001/jama.2026.20375.
Chicago
Hochman, Judith S., Rebecca Anthopolos, Harmony R. Reynolds, Sripal Bangalore, Yifan Xu, Sean M. O’Brien, Stephanie Boumakis, et al. 2026. “Long-Term Survival After Initial Invasive or Conservative Management of Stable Coronary Disease in ISCHEMIA-EXTEND.” JAMA. https://doi.org/10.1001/jama.2026.20375.
Harvard
Hochman, J. S. et al. (2026) ‘Long-Term Survival After Initial Invasive or Conservative Management of Stable Coronary Disease in ISCHEMIA-EXTEND’, JAMA. doi:10.1001/jama.2026.20375.
IEEE
J. S. Hochman et al., “Long-Term Survival After Initial Invasive or Conservative Management of Stable Coronary Disease in ISCHEMIA-EXTEND,” JAMA, 2026, doi: 10.1001/jama.2026.20375.
BibTeX
@article{hochman2026long,
title = {{Long-Term Survival After Initial Invasive or Conservative Management of Stable Coronary Disease in ISCHEMIA-EXTEND}},
author = {Hochman, Judith S. and Anthopolos, Rebecca and Reynolds, Harmony R. and Bangalore, Sripal and Xu, Yifan and O’Brien, Sean M. and Boumakis, Stephanie and Chang, Michelle and Rosenberg, Yves and Senior, Roxy and Banfield, Ann and Goodman, Shaun G. and Lopes, Renato D. and Pracoń, Radosław and Lopez-Sendon, Jose Luis and Steg, Philippe Gabríel and Maggioni, Aldo Pietro and Newman, Jonathan D. and Berger, Jeffrey S. and Sidhu, Mandeep S. and White, Harvey Douglas and Troxel, Andrea B. and Harrington, Robert A. and Boden, William E. and Stone, Gregg W. and Mark, Daniel B. and Spertus, John A. and Maron, David Joel and Guzmán, Luis and Hillis, Graham S. and others},
journal = {JAMA},
year = {2026},
doi = {10.1001/jama.2026.20375},
url = {https://doi.org/10.1001/jama.2026.20375}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Coronary Interventions and Diagnostics
- stable coronary artery disease
- invasive management
- conservative treatment
- coronary angiography
- revascularization
- guideline-directed medical therapy
- long-term survival
- all-cause mortality
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Hochman, J. S., Anthopolos, R., Reynolds, H. R., Bangalore, S., Xu, Y., O’Brien, S. M., Boumakis, S., Chang, M., Rosenberg, Y., Senior, R., Banfield, A., Goodman, S. G., Lopes, R. D., Pracoń, R., Lopez-Sendon, J. L., Steg, P. G., Maggioni, A. P., Newman, J. D., Berger, J. S., . . . John, M. G. B. (2026). Long-Term Survival After Initial Invasive or Conservative Management of Stable Coronary Disease in ISCHEMIA-EXTEND. JAMA. https://doi.org/10.1001/jama.2026.20375
How many times has this paper been cited?
1 times, according to OpenAlex on 17 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at PubMed Central: sign in and open the full text from this page.
Who wrote this paper?
Judith S. Hochman, Rebecca Anthopolos, Harmony R. Reynolds, Sripal Bangalore, Yifan Xu, Sean M. O’Brien, Stephanie Boumakis, Michelle Chang, Yves Rosenberg, Roxy Senior, Ann Banfield, Shaun G. Goodman and 196 more.
What is the DOI of this paper?
10.1001/jama.2026.20375, permanently at https://doi.org/10.1001/jama.2026.20375. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 17 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.